Abstract
Pregnancy after heart valve replacement is highly risky for both the mother and child due to the aggravation of maternal heart function and the adverse effects of some drugs, such as anticoagulant or antiarrhythmic drugs.
The recent decrease in the prevalence of rheumatic heart disease among young women has also decreased the use of mechanical heart valves. Developments in cardiac surgery have replaced mechanical heart valves with bioprosthetic heart valves. However, advances in cardiac surgery have even enabled women with mechanical heart valves to survive for a long term. For such women, long-term management of coagulability is absolutely necessary. The management of pregnancy after mechanical valve replacement is most difficult due to this need for anticoagulant therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
North RA, Sadler L, Stewart AW, McCowan LM, Kerr AR, White HD (1999) Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation 99:2669–2676
American College of Obstetricians and Gynecologists: Cardiac diseases in pregnancy. Technical Bulletin No 168, 1992
Elkayam U, Bitar F (2005) Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol 46:403–410
Cleuziou J, Hörer J, Kaemmerer H, Teodorowicz A, Kasnar-Samprec J, Schreiber C, Lange R (2010) Pregnancy does not accelerate biological valve degeneration. Int J Cardiol 145(3):418–421. https://doi.org/10.1016/j.ijcard.2010.04.095. Epub 2010 Jun 3
Hanania G, Thomas D, Michel PL, Garbarz E, Age C, Millaire A, Acar J (1994) Pregnancy and prosthetic heart valves: a French cooperative retrospective study of 155 cases. Eur Heart J 15(12):1651–1658
Taylor J (2011) The first ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 32:3055–3056
Chan WS, Anand S, Ginsberg JS (2000) Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 160:191–196
Nassar AH, Hobeika EM, Abd Essamad HM, Taher A, Khalil AM, Usta IM (2004) Pregnancy outcome in women with prosthetic heart valves. Am J Obstet Gynecol 191:1009–1013
Greer IA (2002) Exploring the role of low-molecular-weight heparins in pregnancy. Semin Thromb Hemost 28(Suppl 3):25–31
Hall JG, Pauli RM, Wilson KM (1980) Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68:122–140
Ayhan A, Yapar EG, Yuce K, Kisnisci HA, Nazli N, Ozmen F (1991) Pregnancy and its complications after cardiac valve replacement. Int J Gynaecol Obstet 35:117–122
Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO, American College of Chest Physicians (2012) VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e691S–e736S. https://doi.org/10.1378/chest.11-2300
Kaneko T, Aranki SF (2013) Anticoagulation for prosthetic valves. Thrombosis 2013:346752. https://doi.org/10.1155/2013/346752. Epub 2013 Nov 4. Review
Kawamata K (2007) Risk and pregnancy outcome in women with prosthetic mechanical heart valve replacement. Circ J 71:211–213
Inoue H, Nozawa T, Okumura K, Iwasa A, Lee JD, Shimizu A et al (2004) Attitudes of Japanese cardiologists toward anticoagulation for non- valvular atrial fibrillation and reasons for its underuse. Circ J 68:417–421
Nozawa T, Inoue H, Iwasa A, Okumura K, Jong-dae L, Shimizu A et al (2004) Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation. Circ J 68:29–34
Uetsuka Y, Hosoda S, Kasanuki H, Aosaki M, Murasaki K, Ooki K et al (2000) Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: a preliminary report from a single institution using conversion from thrombotest to PT-INR. Heart Vessel 15:124–128
Yamaguchi T (2000) Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial: Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke 31:817–821
Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M (1999) Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33:1637–1641
McKenna R, Cole ER, Vasan U (1983) Is warfarin sodium contraindicated in the lactating mother? J Pediatr 103(2):325–327
El-Hamamsy I, Eryigit Z, Stevens LM et al (2010) Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet 376:524–531
Morimoto K, Hoashi T, Kagisaki K et al (2015) Impact of Ross operation on outcome in young female adult patients wanting to have children. Circ J 79(9):1976–1983
Dore A, Somerville J (1997) Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J 18:1659–1662
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Kawamata, K. (2019). Pregnancy After Cardiac Valve Replacement. In: Ikeda, T., Aoki-Kamiya, C. (eds) Maternal and Fetal Cardiovascular Disease. Springer, Singapore. https://doi.org/10.1007/978-981-10-1993-7_15
Download citation
DOI: https://doi.org/10.1007/978-981-10-1993-7_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1991-3
Online ISBN: 978-981-10-1993-7
eBook Packages: MedicineMedicine (R0)